Publications by authors named "Martin Stenstrom"

Claim this Profile
P
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
Martin Stenström, Helén Carlsson Nyhlén, Marie Törngren, David Liberg, Birgitta Sparre

J Dermatol Sci· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden.
Eva Källberg, Martin Stenström, David Liberg, Fredrik Ivars, Tomas Leanderson

BMC Immunol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cells.
Sofia Helmersson, Martin Stenström, Tomas Leanderson, Fredrik Ivars

Int Immunopharmacol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus.
Christian Lood, Martin Stenström, Helena Tydén, Birgitta Gullstrand, Eva Källberg

Arthritis Res Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757.
Martin Stenström, Per Anderson, Lena Eroukhmanoff, Tomas Leanderson, Fredrik Ivars

Int Immunopharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.
Per Björk, Anders Björk, Thomas Vogl, Martin Stenström, David Liberg

PLoS Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
Julia Rolf, Emma Berntman, Martin Stenström, Emma M K Smith, Robert Månsson

Mol Immunol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
Martin Stenström, Markus Sköld, Asa Andersson, Susanna L Cardell

Immunology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase.
Jorgen Borg, Pernilla Nevsten, Reine Wallenberg, Martin Stenstrom, Susanna Cardell

J Biotechnol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.
Nadia Duarte, Martin Stenström, Susana Campino, Marie-Louise Bergman, Marie Lundholm

J Immunol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
Martin Stenström, Markus Sköld, Anna Ericsson, Lucie Beaudoin, Stephane Sidobre

Eur J Immunol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
Markus Sköld, Martin Stenström, Stephane Sidobre, Petter Höglund, Mitchell Kronenberg

Immunology· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis